{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:46:02Z","timestamp":1695570362933},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.intimp.2007.03.006","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T11:10:29Z","timestamp":1177153829000},"page":"1033-1043","source":"Crossref","is-referenced-by-count":4,"title":["Immune reconstitution after autologous hematopoietic transplantation with Lin\u2212, CD34+, Thy-1lo selected or intact stem cell products"],"prefix":"10.1016","volume":"7","author":[{"given":"Rakesh K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Varney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Leutzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman","family":"Buyukberber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Inwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rifkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Talmadge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2007.03.006_bib1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1200\/JCO.1989.7.11.1621","article-title":"Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy","volume":"7","author":"Gribben","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2007.03.006_bib2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1994.12.6.1177","article-title":"Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma","volume":"12","author":"Rohatiner","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2007.03.006_bib3","first-page":"1975","article-title":"Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma","volume":"10","author":"Haas","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2007.03.006_bib4","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/bjc.1998.381","article-title":"Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?","volume":"77","author":"Dreger","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2007.03.006_bib5","first-page":"521","article-title":"The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma","volume":"4","author":"Villanueva","year":"2006","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.intimp.2007.03.006_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.seminhematol.2006.07.006","article-title":"Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B","volume":"43","author":"Nademanee","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.intimp.2007.03.006_bib7","first-page":"15","article-title":"Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation","volume":"11","author":"Hardingham","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib8","first-page":"257","article-title":"Ex-vivo purging of hematopoietic progenitor cells","volume":"3","author":"de","year":"2004","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.intimp.2007.03.006_bib9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","article-title":"Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma","volume":"325","author":"Gribben","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2007.03.006_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/scd.1.1993.2.7","article-title":"Gene transfer into human hematopoietic progenitor cells: a review of current clinical protocols","volume":"2","author":"Brenner","year":"1993","journal-title":"J Hematother"},{"key":"10.1016\/j.intimp.2007.03.006_bib11","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/bbmt.2001.v7.pm11787531","article-title":"Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma","volume":"7","author":"Vose","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib12","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.1997.15.6.2288","article-title":"Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study","volume":"15","author":"McQuaker","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2007.03.006_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bmt.1702631","article-title":"Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study","volume":"26","author":"Colombat","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib14","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1182\/blood.V90.7.2830","article-title":"Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting","volume":"90","author":"Lopez","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701862","article-title":"Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery","volume":"24","author":"Dreger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/1099-1069(200009)18:3<111::AID-HON657>3.0.CO;2-#","article-title":"Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests","volume":"18","author":"Davies","year":"2000","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.intimp.2007.03.006_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V86.1.381.bloodjournal861381","article-title":"Purified CD34+Lin\u2212Thy+ stem cells do not contain clonal myeloma cells","volume":"86","author":"Gazitt","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00282-997-0252-8","article-title":"Studies of T cell reconstitution after hematopoietic stem cell transplant","volume":"39","author":"Autran","year":"1997","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.intimp.2007.03.006_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1701581","article-title":"Immune reconstitution following allogeneic peripheral blood stem cell transplants","volume":"23","author":"Shenoy","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1701197","article-title":"Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation","volume":"21","author":"Nolte","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0609.1996.tb00719.x","article-title":"Immune recovery after autologous or rhG-CSF primed PBSC transplantation","volume":"56","author":"Rosillo","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.intimp.2007.03.006_bib22","first-page":"675","article-title":"The combination of stem cell transplantation and immunotherapy: future potential","volume":"8","author":"Talmadge","year":"1994","journal-title":"In Vivo"},{"key":"10.1016\/j.intimp.2007.03.006_bib23","first-page":"53","article-title":"Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood","volume":"18","author":"Mills","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib24","first-page":"411","article-title":"Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor","volume":"13","author":"Weaver","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib25","first-page":"101","article-title":"Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation","volume":"17","author":"Talmadge","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib26","first-page":"3107","article-title":"Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation","volume":"59","author":"Singh","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2007.03.006_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bmt.1701518","article-title":"Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products","volume":"23","author":"Singh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib28","first-page":"285","article-title":"Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants","volume":"9","author":"Henon","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1700626","article-title":"Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow","volume":"19","author":"Talmadge","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib30","first-page":"469","article-title":"Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation","volume":"12","author":"Roberts","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0301-472X(00)00169-7","article-title":"Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution","volume":"28","author":"Michallet","year":"2000","journal-title":"Exp Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2007.03.006_bib32","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/sj.bmt.1704848","article-title":"Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future","volume":"35","author":"Fry","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/15258160050196777","article-title":"Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation","volume":"9","author":"Nachbaur","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.intimp.2007.03.006_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/ejso.1999.0736","article-title":"Telomerase activity and lymphovascular invasion in breast cancer","volume":"26","author":"Mokbel","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.intimp.2007.03.006_bib35","first-page":"1100","article-title":"Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study","volume":"84","author":"Laurenti","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2007.03.006_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/107999099314054","article-title":"Expression of interleukin-10 in isolated CD8+ T cells and monocytes from growth factor-mobilized peripheral blood stem cell products: a mechanism of immune dysfunction","volume":"19","author":"Varney","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.intimp.2007.03.006_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jlb.61.5.583","article-title":"Monocytes from mobilized stem cell products induce T-cell apoptosis","volume":"61","author":"Ino","year":"1997","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2007.03.006_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.intimp.2007.03.006_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bmt.1701518","article-title":"Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products","volume":"23","author":"Singh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bmt.1701889","article-title":"Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts","volume":"24","author":"Behringer","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.exphem.2005.05.005","article-title":"A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation","volume":"33","author":"Broers","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.intimp.2007.03.006_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2006.06244.x","article-title":"Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children","volume":"135","author":"Schwinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.intimp.2007.03.006_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00007890-198905000-00024","article-title":"Promotion of fetal liver engraftment by T cells in a murine semiallogeneic model without graft-versus-host reaction","volume":"47","author":"Navarro","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2007.03.006_bib44","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1182\/blood.V87.9.3984.bloodjournal8793984","article-title":"Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts","volume":"87","author":"Roux","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib45","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1182\/blood.V91.7.2588","article-title":"Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors","volume":"91","author":"Bomberger","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V64.2.380.380","article-title":"Defective interleukin-2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin-2","volume":"64","author":"Welte","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib47","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood.V78.11.3076.3076","article-title":"Lymphokine profile in bone marrow transplant recipients","volume":"78","author":"Schneider","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib48","first-page":"187","article-title":"Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact","volume":"13","author":"Lum","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib49","first-page":"1543","article-title":"Time course of interferon-g production deficiency after autologous and allogeneic stem cell transplantation for malignancies","volume":"23","author":"Hanenberg","year":"1995","journal-title":"Exp Hematol"},{"key":"10.1016\/j.intimp.2007.03.006_bib50","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1182\/blood.V74.6.2270.2270","article-title":"T cell ontogeny after autologous bone marrow tranplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4+ and CD8+ cells even in the presence of exogenous IL-2","volume":"74","author":"Cayeux","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bmt.1701780","article-title":"High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths","volume":"23","author":"Baker","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.intimp.2007.03.006_bib52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/BF01526798","article-title":"Effect of adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expression","volume":"37","author":"Asano","year":"1993","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.intimp.2007.03.006_bib53","first-page":"1303","article-title":"Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer","volume":"56","author":"Lee","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2007.03.006_bib54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S1567-5769(03)00014-6","article-title":"Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy","volume":"3","author":"Talmadge","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2007.03.006_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01527407","article-title":"Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes","volume":"41","author":"Maeurer","year":"1995","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.intimp.2007.03.006_bib56","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0145-2126(92)90009-V","article-title":"Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis","volume":"16","author":"Aguilar-Santelises","year":"1992","journal-title":"Leuk Res"},{"key":"10.1016\/j.intimp.2007.03.006_bib57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.V90.1.453","article-title":"Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation","volume":"90","author":"Zeng","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib58","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V97.8.2514","article-title":"Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants","volume":"97","author":"Volpi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib59","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","article-title":"Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease","volume":"86","author":"Pan","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib60","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.4049\/jimmunol.156.9.3486","article-title":"Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers","volume":"156","author":"Coventry","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2007.03.006_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.184.1.159","article-title":"Translational control of interleukin 2 messenger RNA as a molecular mechanism of T cell anergy","volume":"184","author":"Garcia","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2007.03.006_bib62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood.V91.1.347","article-title":"Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells","volume":"91","author":"Tanaka","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2005.07.008","article-title":"Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention","volume":"16","author":"Whiteside","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.intimp.2007.03.006_bib64","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1182\/blood.V97.12.3851","article-title":"Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression","volume":"97","author":"Krishnan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2007.03.006_bib65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00262-004-0521-0","article-title":"Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?","volume":"53","author":"Whiteside","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.intimp.2007.03.006_bib66","first-page":"5344","article-title":"Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma","volume":"58","author":"Reichert","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2007.03.006_bib67","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1158\/1078-0432.CCR-06-0944","article-title":"Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms","volume":"12","author":"Lizee","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.intimp.2007.03.006_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","article-title":"Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression","volume":"16","author":"Serafini","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.intimp.2007.03.006_bib69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1994.tb21713.x","article-title":"Gene marking and autologous bone marrow transplantation","volume":"716","author":"Brenner","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.intimp.2007.03.006_bib70","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood.V79.10.2694.bloodjournal79102694","article-title":"An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer","volume":"79","author":"Rill","year":"1992","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576907000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576907000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T14:57:00Z","timestamp":1683817020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576907000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1567576907000896"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2007.03.006","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}